Delivery Order SPE2DX22D0010-SPE2D826FAS31
Award Date 10/29/25
Potential Completion Date 10/30/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a $21,395.38 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This award was competitively awarded...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $67,832.46, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Department's Medical Supply Chain awarded a $45,744.59 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger indefinite delivery contract vehicle. Performance will be executed from...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta ER Tabs 27mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $8,217.60 with an ultimate completion date of August 12, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Concerta ER Tabs 27mg, a medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $34,825.79, represents a non-set-aside competitive award and is scheduled for completion by July 31, 2025. The contract will be fulfilled from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order has a ceiling value of $9,502.20 and is scheduled for completion by July 29, 2025. The award was made on a competitive basis with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate product commonly used for attention deficit hyperactivity disorder treatment. This firm fixed-price delivery order, valued at $17,783.70 with an ultimate completion date of July 2, 2025, was competitively awarded without set-aside provisions and will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $9,872.70 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $13,437.60 to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 36mg. This competitively awarded, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement action. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,925.61 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Concerta ER Tabs 36mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania....